484 related articles for article (PubMed ID: 21129444)
1. The complexities of obesity and diabetes with the development and progression of pancreatic cancer.
Bao B; Wang Z; Li Y; Kong D; Ali S; Banerjee S; Ahmad A; Sarkar FH
Biochim Biophys Acta; 2011 Apr; 1815(2):135-46. PubMed ID: 21129444
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.
Pothuraju R; Rachagani S; Junker WM; Chaudhary S; Saraswathi V; Kaur S; Batra SK
J Exp Clin Cancer Res; 2018 Dec; 37(1):319. PubMed ID: 30567565
[TBL] [Abstract][Full Text] [Related]
5. The Role of Type 2 Diabetes in Pancreatic Cancer.
George S; Jean-Baptiste W; Yusuf Ali A; Inyang B; Koshy FS; George K; Poudel P; Chalasani R; Goonathilake MR; Waqar S; Mohammed L
Cureus; 2022 Jun; 14(6):e26288. PubMed ID: 35898377
[TBL] [Abstract][Full Text] [Related]
6. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
[TBL] [Abstract][Full Text] [Related]
7. Obesity, diabetes mellitus, and pancreatic carcinogenesis: Correlations, prevention, and diagnostic implications.
Ruze R; Chen Y; Xu R; Song J; Yin X; Wang C; Xu Q
Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188844. PubMed ID: 36464199
[TBL] [Abstract][Full Text] [Related]
8. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.
Li D; Abbruzzese JL
Clin Cancer Res; 2010 Sep; 16(17):4313-8. PubMed ID: 20647474
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
10. [Pancreatitis, pancreatic cancer and obesity: hypothesis and facts].
Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
Eksp Klin Gastroenterol; 2014; (9):4-10. PubMed ID: 25916125
[TBL] [Abstract][Full Text] [Related]
11. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
14. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Strategies for Insulin Sensitivity in Obesity and Cancer: Thiazolidinediones and Metformin.
Biondo LA; Teixeira AAS; de O S Ferreira KC; Neto JCR
Curr Pharm Des; 2020; 26(9):932-945. PubMed ID: 31969093
[TBL] [Abstract][Full Text] [Related]
16. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
17. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
Panunti B; Fonseca V
Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
[TBL] [Abstract][Full Text] [Related]
18. Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms.
Zhou B; Wu D; Liu H; Du LT; Wang YS; Xu JW; Qiu FB; Hu SY; Zhan HX
Pancreatology; 2019 Oct; 19(7):941-950. PubMed ID: 31447281
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
20. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
